METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN PEOPLE WITH DIABETES: THE NEED FOR SCREENING AND EARLY INTERVENTION. A CONSENSUS REPORT OF THE AMERICAN DIABETES ASSOCIATION